Pheniramine
CAS : 86-21-5
Ref. 3D-AAA08621
1mg | Arrêté | ||
5mg | Arrêté | ||
10mg | Arrêté | ||
25mg | Arrêté | ||
50mg | Arrêté | ||
100mg | Arrêté |
Informations sur le produit
- 1-Phenyl-1-(2-pyridyl)-3-di-methylaminopropane
- 2-Pyridinepropanamine, N,N-dimethyl-γ-phenyl-
- 2-[α-(2-Dimethylaminoethyl)benzyl]pyridine
- 3-Phenyl-3-(2-pyridyl)-N,N-dimethylpropylamine
- Dimethyl(3-Phenyl-3-(2-Pyridyl)Propyl)Amine
- Feniramina
- N,N-Dimethyl-γ-phenyl-2-pyridinepropanamine
- N,N-dimethyl-3-phenyl-3-(pyridin-2-yl)propan-1-amine
- Nsc 47965
- Pheniramin
- Voir d'autres synonymes
- Propheniramine
- Prophenpyridamine
- Pyridine, 2-[α-[2-(dimethylamino)ethyl]benzyl]-
- Pyriton
- Tripoton
Pheniramine is a medicinal compound that acts as a protein kinase inhibitor. It has been shown to inhibit the growth of tumor cells in Chinese hamsters and human urine, making it an effective anticancer agent. Pheniramine works by inducing apoptosis, or programmed cell death, in cancer cells. This compound is also used as an antihistamine and anti-inflammatory medication due to its ability to block histamine receptors. Pheniramine analogs have been developed as potential inhibitors of kinases involved in cancer cell proliferation and metastasis. With its versatile range of applications, Pheniramine is a promising therapeutic option for various diseases.